• Vol. 39 No. 6, 493–494
  • 15 June 2010

Intravitreal Bevacizumab for the Treatment of Myopic Choroidal Neovascularisation in an Asian Population

135



135 Views
25 Downloads

Download PDF

Myopic choroidal neovascularisation (mCNV) is one of the most common causes of permanent central visual loss in patients with high myopia, and its natural history results in the development of chorioretinal atrophy around the regressed mCNV, causing further progressive central visual loss.

This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.